News | Caregiver Action Network


CAN's Statement Urging the U.S. Senate to Rethink the Drug Pricing Reform Package

Washington, DC (July 7, 2022) – The Caregiver Action Network (CAN) issued the following statement urging the U.S. Senate to rethink the drug pricing reform package:

“We strongly oppose lawmakers’ new reconciliation language as it would double down on failed prescription drug pricing proposals and uses the Medicare program as a pay-for to address their government mismanagement. Time and time again, mature Americans have warned price control policies would cause massive cuts to drug innovation, leading to fewer treatment options and longer wait times for care.

Press Release: Family Caregivers Want Drug Approved for Hallucinations and Delusions

On June 17, 2022, Caregiver Action Network CEO, John Schall, testified in front of the FDA’s Psychopharmacologic Drugs Advisory Committee in support of approving Acadia Pharmaceuticals Inc.’s supplemental new drug application for NUPLAZID to treat the hallucinations and delusions associated with Alzheimer’s Disease psychosis. If approved, the drug would be the first therapy for the treatment of these behaviors associated with Alzheimer’s-related psychosis. 

Press Release: #RareCaregiverAnd: Honoring Those Caring for a Loved One with a Rare Disease

#RareCaregiverAnd: Honoring Those Caring for a Loved One with a Rare Disease 

Each year, World Rare Disease Day is celebrated on February 28th (or 29th in leap years)—the rarest day of the year. This is a global movement to raise awareness for people living with a rare disease, their families, and caregivers. This year, CAN invites you to celebrate with #RareCaregiverAnd